paroxetine has been researched along with ibogaine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ecker, GF; Freissmuth, M; Sarker, S; Sitte, HH; Steiner, I; Sucic, S; Weissensteiner, R | 1 |
| Garbe, K; Glue, P; Hung, CT; Jakobi, H; Lenagh-Glue, Z; Lyudin, A; Winter, H | 1 |
1 trial(s) available for paroxetine and ibogaine
| Article | Year |
|---|---|
Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers.
Topics: Adult; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Half-Life; Healthy Volunteers; Humans; Ibogaine; Male; Paroxetine; Time Factors; Young Adult | 2015 |
1 other study(ies) available for paroxetine and ibogaine
| Article | Year |
|---|---|
The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter.
Topics: Amphetamines; Antidepressive Agents, Tricyclic; Binding Sites; Carbamazepine; HEK293 Cells; Humans; Ibogaine; Paroxetine; Protein Binding; Serotonin Plasma Membrane Transport Proteins | 2010 |